Clinical Uses of Microsatellite Instability Testing in Colorectal Cancer: An Ongoing Challenge-Reference-Cited by-同舟云学术

Clinical Uses of Microsatellite Instability Testing in Colorectal Cancer: An Ongoing Challenge

Published:2007-03-01 Issue:7 Volume:25 Page:754-756
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Boland C. Richard¹

Affiliation:

1. GI Cancer Research Laboratory, Division of Gastroenterology, Department of Internal Medicine, Baylor University Medical Center and Sammons Cancer Center and the Baylor Research Institute, Dallas, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.09.4607

Reference27 articles.

1. Evolution of the Nomenclature for the Hereditary Colorectal Cancer Syndromes

2. Kane MF, Loda M, Gaida GM, et al: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808,1997-811,

3. Clinicopathologic and Pedigree Differences in Amsterdam I–Positive Hereditary Nonpolyposis Colorectal Cancer Families According to Tumor Microsatellite Instability Status

4. Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study

5. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors;Scientific Reports;2023-03-16

2. The Prognostic Impact of Microsatellite Instability on the Outcome of Appendiceal Adenocarcinoma: a National Cancer Database Analysis;Journal of Gastrointestinal Surgery;2023-01-17

3. CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors;2022-09-21

4. CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors;2022-08-10

5. Sitting in class;Classification Made Relevant;2022